for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

REFILE-CureVac taps Swiss contract drugmaker Celonic for COVID-19 vaccine production

(Adds company name to media packaging code)

March 30 (Reuters) - Germany-based CureVac NV said on Tuesday it had partnered with Swiss contract manufacturer Celonic Group to produce more than 100 million doses of its COVID-19 vaccine candidate.

The vaccine, CVnCoV, will be produced at Celonic’s facility in Heidelberg, Germany. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up